Moorfields Mental Well-Being in Chronic Eye Disease Prevalence Study

  • Research type

    Research Study

  • Full title

    Addressing the Impact of the COVID-19 pandemic on the Mental Well-Being of Patients with Chronic Eye Disease in the United Kingdom

  • IRAS ID

    291112

  • Contact name

    Hari Jayaram

  • Contact email

    h.jayaram@nhs.net

  • Sponsor organisation

    Moorfields Eye Hospital NHS Foundation Trust

  • Duration of Study in the UK

    1 years, 0 months, 1 days

  • Research summary

    The COVID-19 pandemic has led to increased social stresses throughout the population of the United Kingdom, which will contribute to an increased prevalence of mental health issues, principally depression and anxiety disorders. In particular this will affect people with chronic degenerative eye diseases such as glaucoma, diabetic retinopathy and age-related macular degeneration with the prevalence of mental well-being unknown in this patient population within the United Kingdom.

    This project will estimate the prevalence of mental health issues and vision related quality of life among patients attending medical retina and glaucoma clinics in the United Kingdom, help understand how these parameters may differ between those patients who attend hospital appointments and those who choose not to attend and explore the relationship between clinical parameters, measures of visual function and vision-related quality of life with mental well-being, in order to identify patient populations at greater risk who would benefit from future input and targeted care.

    This project will generate UK-derived evidence that will help improve the holistic care of patients with chronic eye disease. This change can be delivered through increasing the awareness of clinicians to the mental wellbeing of patients, identifying and initiating basic treatments to improve mental wellbeing at an earlier stage and through the development and strengthening of links with local psychological support services which will all ultimately enhance the quality of life of and overall clinical outcomes of patients with chronic eye disease.

  • REC name

    East of England - Cambridge East Research Ethics Committee

  • REC reference

    21/EE/0012

  • Date of REC Opinion

    12 Feb 2021

  • REC opinion

    Further Information Favourable Opinion